Medicamen Biotech Shareholding Pattern

As of Dec 2025, Medicamen Biotech (MEDICAMEQ) promoter holding 40.46%, FII 0.02%, DII 0.44%, public 32.17%, total shareholders 10,967. For live price, key ratios and the full company profile, see MEDICAMEQ share price.

Promoter Holding 40.46%
FII Holding 0.02%
DII Holding 0.44%
Public Holding 32.17%
Total Shareholders 10,967
As of Dec 2025

MEDICAMEQ Recent Shareholding Changes — Promoter, FII & DII

Medicamen Biotech promoter, FII and DII holding change from Sept 2025 to Dec 2025, FII -0.04%, DII -0.15%. Examine Medicamen Biotech quarterly financials for recent quarterly revenue, profit and EPS trends.

Promoter Holding Change
Sept 2025 to Dec 2025
No Change
FII Holding Change
Sept 2025 to Dec 2025
-0.04%
DII Holding Change
Sept 2025 to Dec 2025
-0.15%
Public Holding Change
Sept 2025 to Dec 2025
-1.18%

Medicamen Biotech Quarterly Shareholding Trend — Promoter, FII, DII & Public

MEDICAMEQ promoter, FII, DII, public and government holding % by quarter — institutional ownership and promoter pledge trends. Review Medicamen Biotech P/E valuation to evaluate earnings-based valuation against sector peers.

Promoter
FII
DII
Public
Government

MEDICAMEQ Shareholding Pattern Data — Quarterly History

Medicamen Biotech quarterly promoter, FII, DII, public holding % and total shareholders. Download as Excel or CSV.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 40.46% 0.02% 0.44% 0.05% 32.17% 26.86% 100.00% 10,967
Sept 2025 40.46% 0.06% 0.59% 0.05% 33.35% 25.50% 100.01% 11,177
Jun 2025 40.46% 0.00% 0.64% 0.05% 31.50% 27.34% 99.99% 10,808
Apr 2025 40.46% 0.22% 0.65% 0.05% 31.58% 27.04% 100.00% 10,592
Mar 2025 43.16% 0.12% 0.69% 0.06% 33.35% 22.63% 100.01% 10,435
Dec 2024 42.99% 0.05% 0.87% 0.06% 32.96% 23.08% 100.01% 10,576
Sept 2024 42.99% 0.06% 1.17% 0.00% 32.43% 23.34% 99.99% 10,792
Jun 2024 42.99% 0.06% 1.17% 0.00% 31.57% 24.21% 100.00% 10,652
Mar 2024 43.21% 0.11% 0.99% 0.00% 31.95% 23.74% 100.00% 10,639
Dec 2023 43.21% 0.21% 0.68% 0.00% 31.90% 24.00% 100.00% 10,252
Sept 2023 43.21% 0.00% 0.00% 0.00% 31.80% 24.99% 100.00% 9,419
Jun 2023 43.21% 0.00% 0.20% 0.00% 31.43% 25.16% 100.00% 8,272
Mar 2023 43.21% 0.00% 0.20% 0.00% 31.49% 25.10% 100.00% 8,233
Dec 2022 43.21% 0.00% 0.20% 0.00% 31.35% 25.24% 100.00% 8,273
Sept 2022 43.21% 0.00% 0.13% 0.00% 30.94% 25.72% 100.00% 8,418
Jun 2022 43.60% 0.00% 0.00% 0.00% 35.02% 21.38% 100.00% 9,107
Mar 2022 43.60% 0.00% 0.00% 0.00% 34.30% 22.10% 100.00% 9,300
Dec 2021 43.60% 0.00% 0.00% 0.00% 34.23% 22.18% 100.01% 9,140
Sept 2021 44.83% 0.00% 0.00% 0.00% 33.17% 21.99% 99.99% 5,595
Jun 2021 44.83% 0.00% 0.00% 0.00% 32.97% 22.20% 100.00% 5,263
Mar 2021 44.83% 0.00% 0.00% 0.00% 33.04% 22.12% 99.99% 4,965
Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 40.46% 0.02% 0.44% 0.05% 32.17% 26.86% 100.00% 10,967
Sept 2025 40.46% 0.06% 0.59% 0.05% 33.35% 25.50% 100.01% 11,177
Jun 2025 40.46% 0.00% 0.64% 0.05% 31.50% 27.34% 99.99% 10,808
Apr 2025 40.46% 0.22% 0.65% 0.05% 31.58% 27.04% 100.00% 10,592
Mar 2025 43.16% 0.12% 0.69% 0.06% 33.35% 22.63% 100.01% 10,435
Dec 2024 42.99% 0.05% 0.87% 0.06% 32.96% 23.08% 100.01% 10,576
Sept 2024 42.99% 0.06% 1.17% 0.00% 32.43% 23.34% 99.99% 10,792
Jun 2024 42.99% 0.06% 1.17% 0.00% 31.57% 24.21% 100.00% 10,652
Mar 2024 43.21% 0.11% 0.99% 0.00% 31.95% 23.74% 100.00% 10,639
Dec 2023 43.21% 0.21% 0.68% 0.00% 31.90% 24.00% 100.00% 10,252
Sept 2023 43.21% 0.00% 0.00% 0.00% 31.80% 24.99% 100.00% 9,419
Jun 2023 43.21% 0.00% 0.20% 0.00% 31.43% 25.16% 100.00% 8,272
Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 40.46% 0.02% 0.44% 0.05% 32.17% 26.86% 100.00% 10,967
Dec 2024 42.99% 0.05% 0.87% 0.06% 32.96% 23.08% 100.01% 10,576
Dec 2023 43.21% 0.21% 0.68% 0.00% 31.90% 24.00% 100.00% 10,252
Dec 2022 43.21% 0.00% 0.20% 0.00% 31.35% 25.24% 100.00% 8,273
Dec 2021 43.60% 0.00% 0.00% 0.00% 34.23% 22.18% 100.01% 9,140